Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris

2003 ◽  
Vol 48 (1) ◽  
pp. 68-75 ◽  
Author(s):  
Alice B. Gottlieb ◽  
Salman Masuda ◽  
Rallapalli Ramamurthi ◽  
Ahsan Abdulghani ◽  
Pat Romano ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Psoriasis Vulgaris ◽  
Severe Psoriasis ◽  
Infliximab Treatment ◽  
Factor Α ◽  
Necrosis Factor

A Humanized Anti-Tumor Necrosis Factor-α Monoclonal Antibody That Acts as a Partial, Competitive Antagonist of the Template Antibody

Hybridoma ◽  
1994 ◽  
Vol 13 (3) ◽  
pp. 183-190 ◽  
Author(s):  
PHILIP R. TEMPEST ◽  
ELENA BARBANTI ◽  
PATRICIA BREMNER ◽  
FRANK J. CARR ◽  
MARTA GHISLIERI ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Competitive Antagonist ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

mAbs ◽  
2010 ◽  
Vol 2 (4) ◽  
pp. 428-439 ◽  
Author(s):  
David J. Shealy ◽  
Ann Cai ◽  
Kim Staquet ◽  
Audrey Baker ◽  
Eilyn R. Lacy ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Human Monoclonal Antibody ◽  
Human Tumor ◽  
Human Tumor Necrosis Factor ◽  
Factor Α ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document